Biogen receives EC approval for QALSODY to treat rare genetic form of ALS EP News Bureau May 31, 2024 EC granted marketing authorisation under exceptional circumstances and maintained orphan designation for QALSODY (tofersen) for…
Kyowa Kirin gets EC approval for CRYSVITA (burosumab) to treat X-Linked hypophosphataemia in older… EP News Bureau Oct 2, 2020 It was previously approved for the treatment of XLH with radiographic evidence of bone disease in children one year of age and…
